{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:28:34Z","timestamp":1790681314532,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ijpddr.2020.12.003","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T03:36:14Z","timestamp":1608262574000},"page":"25-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["HDAC inhibitors Tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics"],"prefix":"10.1016","volume":"15","author":[{"given":"Carlla Assis","family":"Araujo-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanderley","family":"De Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Martins-Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4768-1555","authenticated-orcid":false,"given":"Rossiane C.","family":"Vommaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2020.12.003_bib1","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00436-020-06668-6","article-title":"Imidazole derivatives as antiparasitic agents and use of molecular modeling to investigate the structure\u2013activity relationship","volume":"119","author":"Adeyemi","year":"2020","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/icb.2011.97","article-title":"HDAC inhibitors in parasitic diseases","volume":"90","author":"Andrews","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/EC.5.1.62-76.2006","article-title":"Pair of unusual GCN5 histone acetyltransferases and ADA2 homologues in the Protozoan parasite toxoplasma gondii","volume":"5","author":"Bhatti","year":"2006","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib4","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.20082826","article-title":"Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites","volume":"206","author":"Bougdour","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib5","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor","volume":"132","author":"Butler","year":"2010","journal-title":"Tubastatin A. J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2017.00460","article-title":"Mitochondrial VDAC1: a key gatekeeper as potential therapeutic target","volume":"8","author":"Camara","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijpddr.2016.12.005","article-title":"Effect of clinically approved HDAC inhibitors on Plasmodium , Leishmania and Schistosoma parasite growth","volume":"7","author":"Chua","year":"2017","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib8","first-page":"53","article-title":"Transcription regulation by class III histone deacetylases (HDACs)-Sirtuins. Transl","volume":"3","author":"Dai","year":"2008","journal-title":"Oncogenomics"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib9","doi-asserted-by":"crossref","first-page":"13143","DOI":"10.1073\/pnas.93.23.13143","article-title":"Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase","volume":"93","author":"Darkin-Rattray","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1039\/C1MD00022E","article-title":"Esterprodrugs of ciprofloxacin as DNA-gyrase inhibitors: synthesis, antiparasitic evaluation and docking studies","volume":"2","author":"Dubar","year":"2011","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1017\/S0031182012000765","article-title":"Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology","volume":"139","author":"Dubey","year":"2012","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpddr.2015.05.004","article-title":"Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites","volume":"5","author":"Engel","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cbpa.2020.05.008","article-title":"Targeting histone acetylation\/deacetylation in parasites: an update (2017\u20132020)","volume":"57","author":"Fioravanti","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0166-6851(02)00282-7","article-title":"Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics","volume":"126","author":"Gelb","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd2227","volume":"6","author":"Grant","year":"2007","journal-title":"Vorinostat. Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib16","series-title":"Toxoplasmosis","first-page":"125","author":"Halonen","year":"2013"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib17","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1021\/acs.jmedchem.5b01478","article-title":"Structure-based design and synthesis of novel inhibitors targeting HDAC8 from schistosoma mansoni for the treatment of schistosomiasis","volume":"59","author":"Heimburg","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib18","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1021\/acs.jmedchem.8b01754","article-title":"Discovery of selective toxoplasma gondii dihydrofolate reductase inhibitors for the treatment of toxoplasmosis","volume":"62","author":"Hopper","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/EC.00088-12","article-title":"Lysine acetylation is widespread on proteins of diverse function and localization in the Protozoan parasite toxoplasma gondii","volume":"11","author":"Jeffers","year":"2012","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib21","doi-asserted-by":"crossref","first-page":"23208","DOI":"10.1074\/jbc.M200455200","article-title":"The carboxyltransferase activity of the apicoplast acetyl-CoA carboxylase of toxoplasma gondii is the target of aryloxyphenoxypropionate inhibitors","volume":"277","author":"Jelenska","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0920-9964(02)00357-2","article-title":"Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii","volume":"62","author":"Jones-Brando","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21769\/BioProtoc.1989","article-title":"Protocol for primary microglial culture preparation","volume":"6","author":"Lian","year":"2016","journal-title":"Bio-Protocol"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijpddr.2018.01.002","article-title":"Synthesis of aminophenylhydroxamate and aminobenzylhydroxamate derivatives and in vitro screening for antiparasitic and histone deacetylase inhibitory activity","volume":"8","author":"Loeuillet","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1574-6968.2008.01130.x","article-title":"Itraconazole affects Toxoplasma gondii endodyogeny","volume":"282","author":"Martins-Duarte","year":"2008","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jac\/dkl180","article-title":"Antiproliferative activities of two novel quinuclidine inhibitors against Toxoplasma gondii tachyzoites in vitro","volume":"58","author":"Martins-Duarte","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib27","doi-asserted-by":"crossref","first-page":"13192","DOI":"10.1073\/pnas.0603391103","article-title":"Apicoplast fatty acid synthesis is essential for organelle biogenesis and parasite survival in Toxoplasma gondii","volume":"103","author":"Mazumdar","year":"2006","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20070140","article-title":"Sirtuins in mammals: insights into their biological function","volume":"404","author":"Michan","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib29","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00922-13","article-title":"The histone code of Toxoplasma gondii comprises conserved and unique posttranslational modifications","volume":"4","author":"Nardelli","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/gb-2004-5-5-224","article-title":"Sirtuins: Sir2-related NAD-dependent protein deacetylases","volume":"5","author":"North","year":"2004","journal-title":"Genome Biol."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib32","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases","volume":"5","author":"Nwaka","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1017\/S0031182018001828","article-title":"Trichostatin A induces Trypanosoma cruzi histone and tubulin acetylation: effects on cell division and microtubule cytoskeleton remodelling","volume":"146","author":"Oliveira Santos","year":"2019","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.parint.2012.12.003","article-title":"Spontaneous cystogenesis in vitro of a Brazilian strain of Toxoplasma gondii","volume":"62","author":"Paredes-Santos","year":"2013","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib35","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1093\/nar\/gkn483","article-title":"DNA organization by the apicoplast-targeted bacterial histone-like protein of Plasmodium falciparum","volume":"36","author":"Ram","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib36","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/EC.00029-12","article-title":"The HU protein is important for apicoplast genome maintenance and inheritance in toxoplasma gondii","volume":"11","author":"Reiff","year":"2012","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-4758(98)01377-5","article-title":"Pathogenesis of toxoplasmic retinochoroiditis","volume":"15","author":"Roberts","year":"1999","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib38","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1073\/pnas.191208598","article-title":"The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species","volume":"98","author":"Ruefli","year":"2001","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib39","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"Ruijter","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib40","doi-asserted-by":"crossref","first-page":"10301","DOI":"10.1128\/MCB.25.23.10301-10314.2005","article-title":"Histone-modifying complexes regulate gene expression pertinent to the differentiation of the Protozoan parasite toxoplasma gondii","volume":"25","author":"Saksouk","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib41","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1016\/j.bmcl.2014.08.060","article-title":"The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors","volume":"24","author":"Sodji","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01640-17","article-title":"Discovery of new inhibitors of toxoplasma gondii via the pathogen box","volume":"62","author":"Spalenka","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700096","article-title":"Isophthalic acid-based HDAC inhibitors as potent inhibitors of HDAC8 from schistosoma mansoni","volume":"350","author":"Stenzel","year":"2017","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib44","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1083\/jcb.151.7.1423","article-title":"The plastid of toxoplasma gondii is divided by association with the centrosomes","volume":"151","author":"Striepen","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib45","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1645\/GE-1043R.1","article-title":"SCRIPTAID and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti\u2013toxoplasma gondii activity IN vitro","volume":"93","author":"Strobl","year":"2007","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-1119(99)00526-0","article-title":"Cloning and characterization of a novel histone acetyltransferase homologue from the protozoan parasite Toxoplasma gondii reveals a distinct GCN5 family member","volume":"242","author":"Sullivan","year":"2000","journal-title":"Gene"},{"key":"10.1016\/j.ijpddr.2020.12.003_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2018.00092","article-title":"Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi","volume":"8","author":"Suraweera","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib48","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1586\/eri.12.100","article-title":"Toxoplasma histone acetylation remodelers as novel drug targets","volume":"10","author":"Vanagas","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib49","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bbrc.2009.06.113","article-title":"Identification of a small molecule SIRT2 inhibitor with selective tumor cytotoxicity","volume":"386","author":"Zhang","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpddr.2020.12.003_bib50","doi-asserted-by":"crossref","first-page":"FSO325","DOI":"10.4155\/fsoa-2018-0037","article-title":"Histone deacetylases as targets for antitrypanosomal drugs","volume":"4","author":"Zuma","year":"2018","journal-title":"Futur. Sci. OA"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320720300518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:52:14Z","timestamp":1761922334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320720300518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":50,"alternative-id":["S2211320720300518"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.12.003","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDAC inhibitors Tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2020.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}